Yuho Ono
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yuho Ono has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Monika Vyas
Department of Pathology Beth Israel Deaconess Medical Center Boston Massachusetts USA
2 shared publications - Osman H. Yilmaz
Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
2 shared publications - Ramy Arnaout
Department of Pathology, Beth Israel Deaconess Medical Center (BIDMC), Boston, MA 02215, USA
2 shared publications - Raul S. Gonzalez
Department of Pathology and Laboratory Medicine Emory University Hospital Atlanta GA USA
2 shared publications - Alexandra Medline1 shared publication
- Amelie Therrien
Celiac Center, Department of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
1 shared publication
Latest Publications
- 17 November 2026
- Published byĀ WileyĀ inĀ Histopathology
Diagnosis of infectious disease pathology on whole slide images: a multiāplatform evaluation with implications for digital laboratory practice
Purpose: Adoption of whole slide imaging (WSI) is accelerating across anatomic pathology practices, yet there is a lack of evidence guiding its use for infectious disease diagnoses. WSI systems usually operate at a maximum of 40X magnification without zāplane depth, appropriately raising concerns about detecting microorganisms. Methods: We assembled a 15ācase panel (with immunohistochemistry [IHC]/special stains where indicated) spanning bacterial, viral, parasitic and fungal infections of various organ systems, including five organismānegative ācontrolsā. An infectious disease pathologist independently reviewed all glass slides to confirm the diagnoses. Eight boardācertified pathologists reviewed cases (blinded to diagnoses) scanned on one of four highāthroughput scanner platforms (Philips SG300, Hamamatsu S360, Pramana (Spectral HT2) and Leica GT450 designated AāD (not in order), two pathologists/platform). As a control group, two additional pathologists reviewed the same cases on glass slides. Additionally, in an attempt to compare image quality among the four WSI platforms, 10 pathologists (blinded to the platform) rated image quality from sideābyāside screenshots in 12 representative cases. Results: Aggregate diagnostic scores were: Scanner A: 78%, Scanner D: 71%, Scanner C: 69% and Scanner B: 65%, (mean 71%) vs. 79% for glassāslide reviewers. Intraāplatform variability between the two pathologists on the same scanner (up to 23% on platform D) exceeded interāplatform differences. WSI reviewers performed nearāequivalently to glassāslide reviewers for large organisms (92% vs. 89%) but lower for small/lowāburden organisms (36% vs. 63%). Conclusions: Diagnostic performance on WSI for infectious disease pathology in this exploratory study varied primarily with organism size and burden, not by platformāspecific image quality differences. WSI is nonāinferior to glass for large organisms, but glass slide review may be superior for small (and low burden) organisms.
- 17 November 2026
- Published byĀ WileyĀ inĀ Histopathology
Diagnosis of infectious disease pathology on whole slide images: a multiāplatform evaluation with implications for digital laboratory practice
Purpose: Adoption of whole slide imaging (WSI) is accelerating across anatomic pathology practices, yet there is a lack of evidence guiding its use for infectious disease diagnoses. WSI systems usually operate at a maximum of 40X magnification without zāplane depth, appropriately raising concerns about detecting microorganisms. Methods: We assembled a 15ācase panel (with immunohistochemistry [IHC]/special stains where indicated) spanning bacterial, viral, parasitic and fungal infections of various organ systems, including five organismānegative ācontrolsā. An infectious disease pathologist independently reviewed all glass slides to confirm the diagnoses. Eight boardācertified pathologists reviewed cases (blinded to diagnoses) scanned on one of four highāthroughput scanner platforms (Philips SG300, Hamamatsu S360, Pramana (Spectral HT2) and Leica GT450 designated AāD (not in order), two pathologists/platform). As a control group, two additional pathologists reviewed the same cases on glass slides. Additionally, in an attempt to compare image quality among the four WSI platforms, 10 pathologists (blinded to the platform) rated image quality from sideābyāside screenshots in 12 representative cases. Results: Aggregate diagnostic scores were: Scanner A: 78%, Scanner D: 71%, Scanner C: 69% and Scanner B: 65%, (mean 71%) vs. 79% for glassāslide reviewers. Intraāplatform variability between the two pathologists on the same scanner (up to 23% on platform D) exceeded interāplatform differences. WSI reviewers performed nearāequivalently to glassāslide reviewers for large organisms (92% vs. 89%) but lower for small/lowāburden organisms (36% vs. 63%). Conclusions: Diagnostic performance on WSI for infectious disease pathology in this exploratory study varied primarily with organism size and burden, not by platformāspecific image quality differences. WSI is nonāinferior to glass for large organisms, but glass slide review may be superior for small (and low burden) organisms.
- 31 March 2025
- Published byĀ Wolters Kluwer HealthĀ inĀ American Journal of Gastroenterology
- Vol.Ā 120 Ā (12) , 2788-2794
Gastric (Foveolar)-Type Dysplasia in Barrett's Esophagus: A Clinical, Molecular, and Long-Term Outcome Study
INTRODUCTION: The aim of this long-term progression study was to evaluate the clinical and pathologic features of gastric type dysplasia in Barrett's esophagus (BE). METHODS: Baseline biopsies from 208 patients with BE from the Seattle prospective cohort were evaluated for the type (gastric or intestinal) and grade of dysplasia. Twenty-seven patients progressed to cancer and 181 did not over the long-term follow-up period. Patients with gastric or intestinal dysplasia were compared with each other regarding their flow cytometric DNA content abnormalities and progression rates to cancer. RESULTS: Of the 59 patients with dysplasia at baseline, 12 (20%) had gastric-type dysplasia only, 24 (41%) had mixed gastric- and intestinal-type dysplasia, and 23 (39%) had intestinal-type dysplasia only. Patients with any gastric-type dysplasia component (alone or mixed with intestinal-type dysplasia) showed a significantly higher rate of high-grade dysplasia (72% vs 23%, P < 0.001) at baseline and cancer development (47% vs 22%, P = 0.05), and a significantly shorter time frame to cancer development (32 vs 64 months, P = 0.008), as well as a longer BE segment length ( P = 0.05), and higher rate of aneuploidy ( P = 0.04), compared with patients with pure intestinal dysplasia. By multivariable analysis, gastric-type dysplasia showed a higher hazard ratio of progression to cancer compared with patients with intestinal-type dysplasia. DISCUSSION: Gastric-type dysplasia is common in BE. Our study suggests that this type of dysplasia may represent a more aggressive form of neoplastic precursor than conventional intestinal-type dysplasia.
- 31 March 2025
- Published byĀ Wolters Kluwer HealthĀ inĀ American Journal of Gastroenterology
- Vol.Ā 120 Ā (12) , 2788-2794
Gastric (Foveolar)-Type Dysplasia in Barrett's Esophagus: A Clinical, Molecular, and Long-Term Outcome Study
INTRODUCTION: The aim of this long-term progression study was to evaluate the clinical and pathologic features of gastric type dysplasia in Barrett's esophagus (BE). METHODS: Baseline biopsies from 208 patients with BE from the Seattle prospective cohort were evaluated for the type (gastric or intestinal) and grade of dysplasia. Twenty-seven patients progressed to cancer and 181 did not over the long-term follow-up period. Patients with gastric or intestinal dysplasia were compared with each other regarding their flow cytometric DNA content abnormalities and progression rates to cancer. RESULTS: Of the 59 patients with dysplasia at baseline, 12 (20%) had gastric-type dysplasia only, 24 (41%) had mixed gastric- and intestinal-type dysplasia, and 23 (39%) had intestinal-type dysplasia only. Patients with any gastric-type dysplasia component (alone or mixed with intestinal-type dysplasia) showed a significantly higher rate of high-grade dysplasia (72% vs 23%, P < 0.001) at baseline and cancer development (47% vs 22%, P = 0.05), and a significantly shorter time frame to cancer development (32 vs 64 months, P = 0.008), as well as a longer BE segment length ( P = 0.05), and higher rate of aneuploidy ( P = 0.04), compared with patients with pure intestinal dysplasia. By multivariable analysis, gastric-type dysplasia showed a higher hazard ratio of progression to cancer compared with patients with intestinal-type dysplasia. DISCUSSION: Gastric-type dysplasia is common in BE. Our study suggests that this type of dysplasia may represent a more aggressive form of neoplastic precursor than conventional intestinal-type dysplasia.
- 30 October 2024
- Published byĀ Wolters Kluwer HealthĀ inĀ American Journal of Gastroenterology
- Vol.Ā 120 Ā (6) , 1353-1366
Ulcerative Jejunitis in Celiac Disease: A 30-Year US Experience
INTRODUCTION: Ulcerative jejunitis (UJ) or ulcerative enteritis (UE) is a rare complication of celiac disease (CeD). Guidelines regarding diagnosis and management are missing, and these cases have seldom been reported in the United States. DESIGN: Case series of CeD in which UE developed at a large academic center in the United States. Clinical presentation, diagnosis, treatment, and evolution of disease were collected. RESULTS: Eight cases were identified (6 male/2 female, mean age 59.5 [38ā77] years). Presentations included intestinal obstruction (n = 3), GI hemorrhage (n = 3), and malabsorption (n = 2). Ulcers were present in the duodenum in 4 patients and exclusively past the angle of Treitz in only 4 cases, which makes the term UE more appropriate than UJ. Six of 8 had T-cell receptor clonal gene rearrangements, and 2 had definite aberrant T cells. Corticosteroids were tried in all patients without improvement, and 5 underwent surgical resection. Three patients received cladribine. One patient received an autologous stem cell transplant, followed by ruxolitinib. Two were subsequently diagnosed with enteropathy-associated T-cell lymphoma, including 1 with cerebral enteropathy-associated T-cell lymphoma, and 1 died from hemophagocytic syndrome. Two are still alive, including only 1 on GFD and 2 were lost to follow-up after surviving at least 30-month posttreatment. DISCUSSION: UE seems a more appropriate term to describe an ulcerative complication of CeD at high risk of obstruction or bleeding. Steroids were not effective. Treatment outcomes were variable, but with a 50% death rate.
- 30 October 2024
- Published byĀ Wolters Kluwer HealthĀ inĀ American Journal of Gastroenterology
- Vol.Ā 120 Ā (6) , 1353-1366
Ulcerative Jejunitis in Celiac Disease: A 30-Year US Experience
INTRODUCTION: Ulcerative jejunitis (UJ) or ulcerative enteritis (UE) is a rare complication of celiac disease (CeD). Guidelines regarding diagnosis and management are missing, and these cases have seldom been reported in the United States. DESIGN: Case series of CeD in which UE developed at a large academic center in the United States. Clinical presentation, diagnosis, treatment, and evolution of disease were collected. RESULTS: Eight cases were identified (6 male/2 female, mean age 59.5 [38ā77] years). Presentations included intestinal obstruction (n = 3), GI hemorrhage (n = 3), and malabsorption (n = 2). Ulcers were present in the duodenum in 4 patients and exclusively past the angle of Treitz in only 4 cases, which makes the term UE more appropriate than UJ. Six of 8 had T-cell receptor clonal gene rearrangements, and 2 had definite aberrant T cells. Corticosteroids were tried in all patients without improvement, and 5 underwent surgical resection. Three patients received cladribine. One patient received an autologous stem cell transplant, followed by ruxolitinib. Two were subsequently diagnosed with enteropathy-associated T-cell lymphoma, including 1 with cerebral enteropathy-associated T-cell lymphoma, and 1 died from hemophagocytic syndrome. Two are still alive, including only 1 on GFD and 2 were lost to follow-up after surviving at least 30-month posttreatment. DISCUSSION: UE seems a more appropriate term to describe an ulcerative complication of CeD at high risk of obstruction or bleeding. Steroids were not effective. Treatment outcomes were variable, but with a 50% death rate.
- Open Access
- 28 March 2024
- Published byĀ Wolters Kluwer HealthĀ inĀ ACG Case Reports Journal
- Vol.Ā 11 Ā (4) , e01305
Spontaneous Tumor Lysis Syndrome Secondary to Metastatic Pancreatic Adenocarcinoma
Kidney injury of unclear etiology. Abdominal imaging and celiac lymph node biopsy were consistent with metastatic pancreatic adenocarcinoma. Her clinical status deteriorated requiring intensive care unit transfer, and her laboratory results were found to be consistent with STLS. Despite treatment, she entered multisystem organ failure and died shortly after. This case adds to the literature of STLS in pancreatic adenocarcinomas....
- 28 March 2024
- Published byĀ Wolters Kluwer HealthĀ inĀ ACG Case Reports Journal
- Vol.Ā 11 Ā (4) , e01305
Open AccessSpontaneous Tumor Lysis Syndrome Secondary to Metastatic Pancreatic Adenocarcinoma
Kidney injury of unclear etiology. Abdominal imaging and celiac lymph node biopsy were consistent with metastatic pancreatic adenocarcinoma. Her clinical status deteriorated requiring intensive care unit transfer, and her laboratory results were found to be consistent with STLS. Despite treatment, she entered multisystem organ failure and died shortly after. This case adds to the literature of STLS in pancreatic adenocarcinomas....
- 6 March 2024
- Published byĀ BMJĀ inĀ Journal of Clinical Pathology
- Vol.Ā 77 Ā (7) , 439-451
Emerging and under-recognised patterns of colorectal carcinoma morphologies: a comprehensive review
While the overwhelming majority of colorectal carcinomas (CRC) are diagnosed as adenocarcinoma not otherwise specified, there are numerous under-recognised morphologic patterns of CRC. These patterns are recognised by the WHO, appear in reporting manuals for the American Joint Committee of Cancer, and/or are listed on synoptic reports, while many other variants have either fallen out of favour or are emerging as future bona fide patterns. Herein, we discuss 13 variants: serrated adenocarcinoma, micropapillary adenocarcinoma, medullary carcinoma, neuroendocrine carcinoma, mucinous adenocarcinoma, signet-ring cell carcinoma, adenosquamous carcinoma, adenoma-like adenocarcinoma, lymphoglandular complex-like CRC, carcinoma with sarcomatoid components, cribriform-comedo-type adenocarcinoma, undifferentiated carcinoma and low-grade tubuloglandular adenocarcinoma. The purpose of this review is to scrutinise these variants by assessing their clinical characteristics, morphologic cues, as well as pitfalls, and address their prognostic significance. Our analysis aims to bring clarity and updated understanding to these variants, offering valuable insights for pathologists. This contributes to more nuanced CRC diagnosis and treatment strategies, highlighting the importance of recognising a broad spectrum of morphologic patterns in CRC.
- 6 March 2024
- Published byĀ BMJĀ inĀ Journal of Clinical Pathology
- Vol.Ā 77 Ā (7) , 439-451
Emerging and under-recognised patterns of colorectal carcinoma morphologies: a comprehensive review
While the overwhelming majority of colorectal carcinomas (CRC) are diagnosed as adenocarcinoma not otherwise specified, there are numerous under-recognised morphologic patterns of CRC. These patterns are recognised by the WHO, appear in reporting manuals for the American Joint Committee of Cancer, and/or are listed on synoptic reports, while many other variants have either fallen out of favour or are emerging as future bona fide patterns. Herein, we discuss 13 variants: serrated adenocarcinoma, micropapillary adenocarcinoma, medullary carcinoma, neuroendocrine carcinoma, mucinous adenocarcinoma, signet-ring cell carcinoma, adenosquamous carcinoma, adenoma-like adenocarcinoma, lymphoglandular complex-like CRC, carcinoma with sarcomatoid components, cribriform-comedo-type adenocarcinoma, undifferentiated carcinoma and low-grade tubuloglandular adenocarcinoma. The purpose of this review is to scrutinise these variants by assessing their clinical characteristics, morphologic cues, as well as pitfalls, and address their prognostic significance. Our analysis aims to bring clarity and updated understanding to these variants, offering valuable insights for pathologists. This contributes to more nuanced CRC diagnosis and treatment strategies, highlighting the importance of recognising a broad spectrum of morphologic patterns in CRC.
- Open Access
- 10 July 2023
- Published byĀ MDPI AGĀ inĀ Preprints.org
Case Report and Mini-Review: Sarcina ventriculi in the Stomach of an 80-Year-Old Female
In infectious disease and clinical microbiology, rarely encountered species are often of special concern simply by virtue of their unfamiliarity, especially in settings of complicated underlying disease. This is all the more so when the infectious agent has an appearance that distinguishes it from most commonly encountered organisms, making it a mystery that must be explained. In this context, it is rare for histopathologists to be more familiar with a bacterial species than clinical microbiologists but Sarcina ventriculi is one such example. Infrequently seen in tissue and even less often in culture, we here report a case of Sarcina ventriculi in the GI tract of a geriatric patient with complex underlying history. A brief discussion of the history, clinical presentation, treatment, and culture conditions of this organism is provided, along with clarification of nomenclature, which has changed and could otherwise be a source of additional confusion in this rarely encountered bacterium.
- 10 July 2023
- Published byĀ MDPI AGĀ inĀ Preprints.org
Open AccessCase Report and Mini-Review: Sarcina ventriculi in the Stomach of an 80-Year-Old Female
In infectious disease and clinical microbiology, rarely encountered species are often of special concern simply by virtue of their unfamiliarity, especially in settings of complicated underlying disease. This is all the more so when the infectious agent has an appearance that distinguishes it from most commonly encountered organisms, making it a mystery that must be explained. In this context, it is rare for histopathologists to be more familiar with a bacterial species than clinical microbiologists but Sarcina ventriculi is one such example. Infrequently seen in tissue and even less often in culture, we here report a case of Sarcina ventriculi in the GI tract of a geriatric patient with complex underlying history. A brief discussion of the history, clinical presentation, treatment, and culture conditions of this organism is provided, along with clarification of nomenclature, which has changed and could otherwise be a source of additional confusion in this rarely encountered bacterium.
- 16 June 2023
- Published byĀ Wolters Kluwer HealthĀ inĀ American Journal of Surgical Pathology
- Vol.Ā 47 Ā (8) , 933-941
Apoptosis, Crypt Dropout, and Equivocal Immunohistochemical Staining May Indicate Cytomegalovirus Infection in Inflammatory Bowel Disease Patients
Cytomegalovirus (CMV) colitis superimposed on inflammatory bowel disease (IBD) can be challenging to diagnose. This study aimed to determine what histologic clues and immunohistochemistry (IHC) utilization practices, if any, can help diagnose CMV superinfection in IBD. Colon biopsies were reviewed from all patients with CMV colitis with and without IBD between 2010 and 2021 at one institution, along with a separate cohort of IBD patients with negative CMV IHC. Biopsies were assessed for histologic features of activity and chronicity, phlebitis, fibrin thrombi, basal crypt apoptosis, CMV viral cytopathic effect (VCE), and CMV IHC positivity. Features between groups were compared, with statistical significance set at P-value P=0.035) and crypt dropout (75% vs. 55%, P=0.045). CMV was detected by IHC in 18 CMV+IBD cases without VCE on hematoxylin and eosin (41%). In the 23 CMV+IBD cases where IHC was performed on all concurrent biopsies, IHC was positive in at least 1 biopsy in 22 cases. Six individual CMV+IBD biopsies with no VCE on hematoxylin and eosin demonstrated equivocal IHC staining. Of these, 5 had evidence of CMV infection. IBD patients with superimposed CMV infection are more likely to demonstrate apoptotic bodies and crypt dropout compared with their noninfected counterparts. Equivocal IHC staining for CMV may indicate true infection in IBD patients, and staining multiple biopsies from the same accession can improve CMV detection.
- 16 June 2023
- Published byĀ Wolters Kluwer HealthĀ inĀ American Journal of Surgical Pathology
- Vol.Ā 47 Ā (8) , 933-941
Apoptosis, Crypt Dropout, and Equivocal Immunohistochemical Staining May Indicate Cytomegalovirus Infection in Inflammatory Bowel Disease Patients
Cytomegalovirus (CMV) colitis superimposed on inflammatory bowel disease (IBD) can be challenging to diagnose. This study aimed to determine what histologic clues and immunohistochemistry (IHC) utilization practices, if any, can help diagnose CMV superinfection in IBD. Colon biopsies were reviewed from all patients with CMV colitis with and without IBD between 2010 and 2021 at one institution, along with a separate cohort of IBD patients with negative CMV IHC. Biopsies were assessed for histologic features of activity and chronicity, phlebitis, fibrin thrombi, basal crypt apoptosis, CMV viral cytopathic effect (VCE), and CMV IHC positivity. Features between groups were compared, with statistical significance set at P-value P=0.035) and crypt dropout (75% vs. 55%, P=0.045). CMV was detected by IHC in 18 CMV+IBD cases without VCE on hematoxylin and eosin (41%). In the 23 CMV+IBD cases where IHC was performed on all concurrent biopsies, IHC was positive in at least 1 biopsy in 22 cases. Six individual CMV+IBD biopsies with no VCE on hematoxylin and eosin demonstrated equivocal IHC staining. Of these, 5 had evidence of CMV infection. IBD patients with superimposed CMV infection are more likely to demonstrate apoptotic bodies and crypt dropout compared with their noninfected counterparts. Equivocal IHC staining for CMV may indicate true infection in IBD patients, and staining multiple biopsies from the same accession can improve CMV detection.
- 24 February 2022
- Published byĀ American Society of Clinical Oncology (ASCO)Ā inĀ JCO Precision Oncology
- Vol.Ā 6 Ā (6) , e2100091
A Case of Prostate Cancer Harboring Androgen Receptor T878A Progesterone-Responsive Mutant Emerging After Abiraterone Acetate Treatment Responding to Darolutamide
- 24 February 2022
- Published byĀ American Society of Clinical Oncology (ASCO)Ā inĀ JCO Precision Oncology
- Vol.Ā 6 Ā (6) , e2100091
A Case of Prostate Cancer Harboring Androgen Receptor T878A Progesterone-Responsive Mutant Emerging After Abiraterone Acetate Treatment Responding to Darolutamide
- 1 October 2021
- Published byĀ ElsevierĀ inĀ Pathology - Research and Practice
- Vol.Ā 226, 153608
Can histologic features predict neoadjuvant therapy response in rectal adenocarcinoma?
- 1 October 2021
- Published byĀ ElsevierĀ inĀ Pathology - Research and Practice
- Vol.Ā 226, 153608
Can histologic features predict neoadjuvant therapy response in rectal adenocarcinoma?
- Open Access
- 13 November 2019
- Published byĀ American Society of HematologyĀ inĀ Blood
- Vol.Ā 134 Ā (Supplement) , 4988
Going Down the Tubes: A Multidisciplinary Root Cause Analysis on a Patient Safety Event Involving Delayed Transfusions
Background The pneumatic tube delivery system (PTDS) has been an integral part of blood bank (BB) operations at our institution ever since its implementation in the early 2000s. Its reliable performance is essential for rapid and accurate delivery of blood products, impacting patient safety and product integrity. However, malfunctioning operational events are not uncommon given PTDS complexity and hospital-wide utilization. In 2018, 33 of 285 (12%) blood products were wasted due to PTDS events at our institution. Here we review the root cause analysis (RCA) of a patient safety event involving delayed transfusions and a wasted blood product causing temporary harm to two patients. Methods Two patients, both hospitalized on the same floor, simultaneously experienced significant delays in red blood cell (RBC) transfusions. One patient with active bleeding experienced a 2-hour delay and another patient with anemia experienced a 50-minute delay before appropriate transfusion occurred. The two patients did not receive their transfusions until their nurses physically retrieved RBC units from the BB. An incident report was filed by a floor nurse, which prompted a RCA involving the laboratory quality and patient safety team, the BB, the hospital maintenance department overseeing the PTDS, and the information systems service controlling programming of the PTDS. Results Operational challenges surrounding the PTDS were central to the multiple root causes identified (see Table). RBC units sent to the floor from the BB were electronically directed to another floor or returned to the BB, which resulted in a waste of one RBC unit. Despite multiple potential contributing factors identified, deeper investigation did not uncover evidence for any specific root cause and the electronic tube transaction history showed normal PTDS operations during the time of the incident, with all transactions appearing as successfully completed within expected timeframes. Neither of the patients involved in this safety event experienced permanent harm. The findings of this investigation were reviewed at our departmental Pathology Morbidity and Mortality conference together with stakeholders from hospital maintenance. Conclusion The root causes for PTDS technical malfunctioning leading to this safety event remain uncertain despite a collaborative RCA. This multidisciplinary retrospective RCA process, however, provided an opportunity for greater awareness of the complex mechanism of the PTDS, promoted awareness of the roles of the various stakeholders involved, and fostered interdepartmental collaboration to prevent future patient safety incidents using quality improvement principles.
- 13 November 2019
- Published byĀ American Society of HematologyĀ inĀ Blood
- Vol.Ā 134 Ā (Supplement) , 4988
Open AccessGoing Down the Tubes: A Multidisciplinary Root Cause Analysis on a Patient Safety Event Involving Delayed Transfusions
Background The pneumatic tube delivery system (PTDS) has been an integral part of blood bank (BB) operations at our institution ever since its implementation in the early 2000s. Its reliable performance is essential for rapid and accurate delivery of blood products, impacting patient safety and product integrity. However, malfunctioning operational events are not uncommon given PTDS complexity and hospital-wide utilization. In 2018, 33 of 285 (12%) blood products were wasted due to PTDS events at our institution. Here we review the root cause analysis (RCA) of a patient safety event involving delayed transfusions and a wasted blood product causing temporary harm to two patients. Methods Two patients, both hospitalized on the same floor, simultaneously experienced significant delays in red blood cell (RBC) transfusions. One patient with active bleeding experienced a 2-hour delay and another patient with anemia experienced a 50-minute delay before appropriate transfusion occurred. The two patients did not receive their transfusions until their nurses physically retrieved RBC units from the BB. An incident report was filed by a floor nurse, which prompted a RCA involving the laboratory quality and patient safety team, the BB, the hospital maintenance department overseeing the PTDS, and the information systems service controlling programming of the PTDS. Results Operational challenges surrounding the PTDS were central to the multiple root causes identified (see Table). RBC units sent to the floor from the BB were electronically directed to another floor or returned to the BB, which resulted in a waste of one RBC unit. Despite multiple potential contributing factors identified, deeper investigation did not uncover evidence for any specific root cause and the electronic tube transaction history showed normal PTDS operations during the time of the incident, with all transactions appearing as successfully completed within expected timeframes. Neither of the patients involved in this safety event experienced permanent harm. The findings of this investigation were reviewed at our departmental Pathology Morbidity and Mortality conference together with stakeholders from hospital maintenance. Conclusion The root causes for PTDS technical malfunctioning leading to this safety event remain uncertain despite a collaborative RCA. This multidisciplinary retrospective RCA process, however, provided an opportunity for greater awareness of the complex mechanism of the PTDS, promoted awareness of the roles of the various stakeholders involved, and fostered interdepartmental collaboration to prevent future patient safety incidents using quality improvement principles.